What the Headlines Get Wrong About the Future of Meat | Bruce Friedrich

What It Covers

Bruce Friedrich, founder of the Good Food Institute and author of *Meat*, examines why alternative protein headlines misrepresent the industry's actual trajectory. He covers the systemic failures of plant-based meat companies, the underestimated science of replicating meat from plants, cultivated meat's regulatory milestones, and why government R&D investment — not venture capital — determines whether price and taste parity is achieved within a viable timeline.

Key Questions Answered

• •The real reason plant-based meat stalled: Beyond Meat's stock falling 99% reflects a product problem, not a consumer rejection of the concept. The core failure was companies entering market without chief science officers, R&D budgets, or understanding of the actual challenge. Impossible Foods took five years and tens of millions of dollars to produce one burger. Most competitors launched inferior, overpriced products with a value proposition of paying more for something less enjoyable — a structurally unwinnable market position.
• •Taste and price remain the only metrics that matter: Survey data consistently shows the top two reasons consumers avoid or abandon plant-based meat are taste and price — not health concerns or ultra-processing fears. Health-related objections, including ultra-processed food concerns, appear to function as post-hoc rationalizations. Consumers who cite processing as a reason still would not have purchased the product due to taste and price. Companies optimizing for health credentials at the expense of palatability are misreading the market.
• •The ultra-processed food label is misapplied to plant-based meat: Studies linking ultra-processed foods to cardiovascular disease have been widely misattributed to plant-based meat. In one frequently cited study, plant-based meat represented 0.2% of calories consumed, while soda accounted for 50 times more. The dataset predated modern plant-based products and included tempeh and tofu. Impossible and Beyond products actually contain more protein, less saturated fat, lower caloric density, zero cholesterol, and some fiber compared to the conventional meat they replace.
• •Cultivated meat may reach parity faster than plant-based meat: The scientific skill set required for cultivated meat — tissue engineering — already exists in biomedical research. Hundreds of trained tissue engineers can transfer directly into cultivated meat R&D. Plant-based meat requires an entirely novel scientific discipline: making plant fats and proteins behave like animal fats and proteins, replicating umami, and solving manufacturing at scale. There is no existing talent pipeline for this, making it structurally harder despite appearing more straightforward.
• •Bioreactor design breakthrough cuts cultivated meat production costs: Vow Foods' CTO, recruited from SpaceX, identified that pharmaceutical bioreactors contain numerous features unnecessary for meat production. Designing purpose-built bioreactors from scratch costs a fraction of repurposing pharma equipment. MosaMeat reduced cost-per-pound from $300,000 to $3 over twelve years on $120 million total funding — a 100,000-fold reduction. Wild Type projects ingredient costs of $9 per pound of salmon. These figures remain above conventional meat but demonstrate a clear downward trajectory.
• •Government R&D investment, not venture capital, is the critical variable: Venture capital cannot fund the infrastructure-scale challenges of alternative proteins. Countries dominating technology sectors — EVs in China, biopharma globally — achieved dominance through government-directed R&D. China holds 8 of the 20 most active alternative protein patents filed in the last five years. South Korea, the UK, Israel, and Singapore punch significantly above their weight. The US lags as a percentage of GDP. GFI's primary strategy is convincing governments to fund open-access science, not supporting individual companies.
• •The plant-based meat industry lacks the B2B supplier ecosystem cultivated meat is building: Cultivated meat has developed specialized companies focused on individual challenges — cell culture media, scaffolding, bioreactor design — allowing consumer-facing companies to focus on product. Plant-based meat companies still handle every stage internally, including a 60-year-old twin-screw extrusion process for texture replication. Creating dedicated B2B suppliers focused on specific plant-based challenges — fat behavior, umami replication, protein digestibility using soy and mycoprotein — is identified as the structural gap most likely to accelerate progress.